166 related articles for article (PubMed ID: 29264196)
1. Developing immunotherapy strategies in the treatment of prostate cancer.
Gulley JL; Madan RA
Asian J Urol; 2016 Oct; 3(4):278-285. PubMed ID: 29264196
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation and immunotherapy for the treatment of prostate cancer.
Gamat M; McNeel DG
Endocr Relat Cancer; 2017 Dec; 24(12):T297-T310. PubMed ID: 28814451
[TBL] [Abstract][Full Text] [Related]
3. Progression in immunotherapy for advanced prostate cancer.
Liang H; Liu Y; Guo J; Dou M; Zhang X; Hu L; Chen J
Front Oncol; 2023; 13():1126752. PubMed ID: 36925917
[TBL] [Abstract][Full Text] [Related]
4. Current management of advanced and castration resistant prostate cancer.
Gomella LG; Petrylak DP; Shayegan B
Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
[TBL] [Abstract][Full Text] [Related]
5. Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer.
Aragon-Ching JB; Williams KM; Gulley JL
Front Biosci; 2007 Sep; 12():4957-71. PubMed ID: 17569623
[TBL] [Abstract][Full Text] [Related]
6. Immune Therapy for Prostate Cancer.
Yeku O; Slovin SF
Cancer J; 2016; 22(5):334-341. PubMed ID: 27749327
[TBL] [Abstract][Full Text] [Related]
7. Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.
Kalina JL; Neilson DS; Comber AP; Rauw JM; Alexander AS; Vergidis J; Lum JJ
Cancers (Basel); 2017 Jan; 9(2):. PubMed ID: 28134800
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?
Laccetti AL; Subudhi SK
Curr Opin Urol; 2017 Nov; 27(6):566-571. PubMed ID: 28825923
[TBL] [Abstract][Full Text] [Related]
9. Exploiting synergy: immune-based combinations in the treatment of prostate cancer.
Burotto M; Singh N; Heery CR; Gulley JL; Madan RA
Front Oncol; 2014; 4():351. PubMed ID: 25566495
[TBL] [Abstract][Full Text] [Related]
10. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
McNeel DG; Bander NH; Beer TM; Drake CG; Fong L; Harrelson S; Kantoff PW; Madan RA; Oh WK; Peace DJ; Petrylak DP; Porterfield H; Sartor O; Shore ND; Slovin SF; Stein MN; Vieweg J; Gulley JL
J Immunother Cancer; 2016; 4():92. PubMed ID: 28031820
[TBL] [Abstract][Full Text] [Related]
11. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
12. Past, Current, and Future of Immunotherapies for Prostate Cancer.
Boettcher AN; Usman A; Morgans A; VanderWeele DJ; Sosman J; Wu JD
Front Oncol; 2019; 9():884. PubMed ID: 31572678
[TBL] [Abstract][Full Text] [Related]
13. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
14. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for prostate cancer - recent progress in clinical trials.
Kipp RT; McNeel DG
Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
[TBL] [Abstract][Full Text] [Related]
16. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccines for prostate cancer.
Cha E; Fong L
Curr Opin Mol Ther; 2010 Feb; 12(1):77-85. PubMed ID: 20140819
[TBL] [Abstract][Full Text] [Related]
18. Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy.
Gomella LG; Gelpi-Hammerschmidt F; Kundavram C
Can J Urol; 2014 Apr; 21(2 Supp 1):48-56. PubMed ID: 24775724
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy: a glimmer of hope for metastatic prostate cancer.
Jindal V
Chin Clin Oncol; 2018 Dec; 7(6):61. PubMed ID: 29860848
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for prostate cancer.
Fong L; Small EJ
Semin Oncol; 2003 Oct; 30(5):649-58. PubMed ID: 14571412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
